Hoffmann-La Roche, also known as Roche Nutley, conducts drug research in the suburban community of Nutley, New Jersey. The company is part of Roche USA and is one of the primary US research facilities for its parent, Swiss drug giant Roche Holdings. It serves as a lead location for Roche's oncology, inflammatory disease, and virology R&D programs, developing drugs to treat conditions including tumorous cancers, asthma, rheumatoid arthritis, hepatitis C virus (HCV), and human papilloma virus (HPV). Hoffmann-La Roche also has extensive programs in gene-based and protein-based biotechnology research.